Loading organizations...
§ Private Profile · Suzhou, Jiangsu, China
Clinical-stage biopharmaceutical company developing oncology drugs.
TOT BIOPHARM has raised $102.0M across 1 funding round.
TOT BIOPHARM has raised $102.0M in total across 1 funding round.
TOT BIOPHARM has raised $102.0M in total across 1 funding round.
TOT BIOPHARM's investors include Cathay Capital, Center Laboratories Limited, Chengwei Capital, Vivo Capital, Yuanta Asia Investment.
TOT BIOPHARM has raised $102.0M across 1 funding round. Most recently, it raised $102.0M Series B in August 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 8, 2018 | $102M Series B | — | Cathay Capital, Center Laboratories Limited, Chengwei Capital, Vivo Capital, Yuanta Asia Investment | Announced |